Machine signal
Active cluster sell — 3 distinct insiders, $4.7M, window ends Oct 1, 2026.
Figures computed from official regulatory filings — .
Analysttarget 367.67 USD (+7%) · consensus 4.21/5 · 10 buy · 4 hold · 0 sell
Ownershipinsiders 4.3% · institutions 99.43% · short 2.3% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Cencora, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
18 buys476 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Krikorian Lazarus | Sell | $298.9K | SEC |
| SANCHEZ ROBERT E | Award | n/a (No price was disclosed in the filing) | SEC |
| GREENBERG LON Rtrack record | Sell | $411.3K | SEC |
| Krikorian Lazarus | Sell | $321.1K | SEC |
| Campbell Elizabeth S | Sell | $3.7M | Unusual size | SEC |
| NALLY DENNIS M | Award | $35.2K | SEC |
| Cooper Ellen | Award | $30.2K | SEC |
| Tyler Lauren M | Award | $30.2K | SEC |
| COLLIS STEVEN H | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| COLLIS STEVEN H | Exercise | $814K | SEC |
| COLLIS STEVEN H | Sell | $2M | SEC |
| Walgreens Boots Alliance Holdings LLC | Sell | $250M | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Walgreens Boots Alliance Holdings LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| NALLY DENNIS M | Award | $31.4K | SEC |